English
Back
Download
Log in to access Online Inquiry
Back to the Top

Hmm?

$Reviva Pharmaceuticals (RVPH.US)$ H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Reviva Pharmaceuticals Holdings (RVPH Research Report) today and set a price target of $20.00.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
17K Views
Comment
Sign in to post a comment
    5214
    Followers
    23
    Following
    75K
    Visitors
    Follow